News in brief: Canopy expands Australian portfolio; Neurotech CEO departs; Elixinol completes US sale by Adam Sheldon September 8, 2026September 9, 2026 Nasdaq and Toronto-listed Canopy Growth has expanded its Australian portfolio with a suite of new products, […]
Elixinol cuts H1 loss and announces deal to sell US hemp business by Adam Sheldon September 2, 2026September 3, 2026
Financial news in brief: Ecofibre looks to sell Ananda Health; product delays hit Elixinol by Steve Jones April 30, 2025April 30, 2025
Ecofibre writes down A$12m as subdued CBD market continues to impact sales by Steve Jones February 20, 2023April 30, 2024
Ecofibre launches low-cost CBD product and pins hope on OTC market to drive profitability by Steve Jones August 23, 2022April 29, 2024
Ecofibre; LGP; Creso Pharma; Rua Bioscience; The Pain Clinic; MGC Pharma by Martin Lane July 28, 2022April 29, 2024
Ecofibre CEO Eric Wang: ‘we’re through the worst, now it’s my job to deliver’ by Steve Jones July 21, 2022April 29, 2024
Ecofibre acquires hemp brand Soul Seed and ploughs ahead with sleep-focused S3 trial by Steve Jones April 28, 2022April 29, 2024
